The Whole Blood Transcriptomic Analysis in Sickle Cell Disease Reveals RUNX3 as a Potential Marker for Vaso-Occlusive Crises
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136338 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Safa Taha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Princess Al Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, College of Medicine and Health …. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Transcriptome, Core Binding Factor Alpha 3 Subunit. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arabian Gulf University, College of Medicine and Health Sciences, Arabian Gulf University.
Abstract (Originalsprache)
Sickle cell disease (SCD) is the most common hemoglobinopathy, caused by a mutation in the β-globin gene of hemoglobin. It predisposes patients to painful Vaso-occlusive crises (VOC) and multi-organ dysfunctions. The disease exhibits significant phenotypic variability, making it challenging to predict severity and outcomes. This study aimed to characterize the whole blood gene expression profile of Bahraini SCD patients, identifying differentially expressed genes during steady-state (n = 10) and VOC (n = 10) compared to healthy controls (n = 8). Analysis revealed 2073 and 3363 dysregulated genes during steady-state and VOC, respectively, compared to controls, with 1078 genes differentially expressed during VOC versus steady-state. Gene Ontology (GO) enrichment analysis highlighted significant deregulation in immune and hematopoietic pathways, including down-regulation of critical genes for immune modulation and hematopoietic balance. Notably, the transcription factor RUNX3, involved in immune cell differentiation and inflammation, was among the 668 down-regulated genes. RUNX3 was four-fold down-regulated in microarray analysis, three-fold in PCR, and showed a mean protein concentration of 11.13 pg/mL during VOC compared to 457.93 pg/mL during steady-state (p < 0.01). These findings suggest that RUNX3 may serve as a potential biomarker for VOC. Future large-scale validation, additional proteomic studies, and functional investigations are recommended to confirm its clinical utility and significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Princess Al Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, College of Medicine and Health Sciences, Arabian Gulf University, Manama P.O. Box 26671, Bahrain.
- Equipe Labélisée Ligue Contre le Cancer, Aix-Marseille University, INSERM, TAGC, UMR1090, 13288 Marseille, France.
ORCID-Profile: Safa Taha, Muna Aljishi, Ameera Sultan, Moiz Bakhiet, Salvatore Spicuglia, Mohamed Belhocine
Förderung
- Arabian Gulf University
- College of Medicine and Health Sciences, Arabian Gulf University
Zitieren
APA
Taha, S., Abdulwahab, H., Aljishi, M., Sultan, A., Bakhiet, M., Spicuglia, S., & Belhocine, M. (2025). The Whole Blood Transcriptomic Analysis in Sickle Cell Disease Reveals RUNX3 as a Potential Marker for Vaso-Occlusive Crises. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136338
Vancouver
Taha S, Abdulwahab H, Aljishi M, Sultan A, Bakhiet M, Spicuglia S, et al. The Whole Blood Transcriptomic Analysis in Sickle Cell Disease Reveals RUNX3 as a Potential Marker for Vaso-Occlusive Crises. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136338
BibTeX
@article{Taha2025,
author = {Taha, Safa and Abdulwahab, Hawra and Aljishi, Muna and Sultan, Ameera and Bakhiet, Moiz and Spicuglia, Salvatore and Belhocine, Mohamed},
title = {The Whole Blood Transcriptomic Analysis in Sickle Cell Disease Reveals RUNX3 as a Potential Marker for Vaso-Occlusive Crises},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136338}
}
EUVIMED